Displaying drugs 401 - 425 of 2796 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Stannous fluoride | 156.71 F2Sn | A medication used to treat dental hypersensitivity, produce enamel, prevent gingivitis and cavities, and prevent periodontal infections. | Caries Prophylactic Agents | |
Stannous chloride | 189.62 Cl2Sn | Stannous chloride is a component of technetium-99m agents indicated for imaging of the skeleton for areas of altered osteogenesis or in the detection of infarcted heart tissue [FDA Label]. | Not Available | |
Squalene | 410.73 C30H50 | Squalene is originally obtained from shark liver oil. It is a natural 30-carbon isoprenoid compound and intermediate metabolite in the synthesis of cholesterol. It is not susceptible to lipid peroxidation... | Polyenes / Triterpenes | |
Spironolactone | 416.573 C24H32O4S | An aldosterone receptor antagonist used to treat edema, hypertension, heart failure, and aldosteronism. | Antihypertensive Agents Indicated for Hypertension / Lactones / Mineralocorticoid Receptor Antagonists / Pregnenes | |
Spirapril | 466.614 C22H30N2O5S2 | Spirapril is an ACE inhibitor class drug used to treat hypertension. | Agents Acting on the Renin-Angiotensin System / Angiotensin-Converting Enzyme Inhibitors | |
Spiramycin | 843.065 C43H74N2O14 | A macrolide antimicrobial agent used in the treatment of various bacterial infections. | Anti-Bacterial Agents / Coccidiostats / Leucomycins / Macrolides | |
Spinosad | 1477.963 C83H132N2O20 | A pediculicide used topically to treat head lice. | Insecticides / Pediculicides | |
Spectinomycin | 332.3496 C14H24N2O7 | An aminocyclitol antibiotic used to treat susceptible strains of Neisseria gonorrhoeae. | Anti-Bacterial Agents / Dioxanes | |
Sparsentan | 592.76 C32H40N4O5S | An endothelin and angiotensin II receptor antagonist indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression. | Agents Acting on the Renin-Angiotensin System / Amides / Angiotensin 2 Receptor Blocker / Angiotensin II receptor antagonists / Angiotensin II Type 1 Receptor Blockers / Angiotensin Receptor Antagonists / BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Dual Endothelin Type A Receptor/Ang II Subtype 1 Receptor Antagonist (DEARA) / Endothelin Receptor Antagonists / OAT3/SLC22A8 Inhibitors / OATP1B3 inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates / Sulfones / Sulfur Compounds | |
Sparfloxacin | 392.3998 C19H22F2N4O3 | A fluoroquinolone antibiotic used to treat bacterial respiratory infections and sinusitis. | Anti-Bacterial Agents / Fluoroquinolones | |
Soy isoflavones | Not Annotated | Not Annotated | Not Annotated | |
Sotorasib | 560.606 C30H30F2N6O3 | An experimental KRAS inhibitor being investigated for the treatment of KRAS G12C mutant non small cell lung cancer, colorectal cancer, and appendix cancer. | Immune Checkpoint Inhibitors | |
Sotalol | 272.364 C12H20N2O3S | A methane sulfonanilide beta adrenergic antagonist used to treat life-threatening ventricular arrhythmias and to maintain sinus rhythm in atrial fibrillation or flutter. | Beta Blocking Agents, Non-Selective / Beta Blocking Agents, Non-Selective, and Thiazides | |
Sotagliflozin | 424.94 C21H25ClO5S | An orally administered dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 1, antagonists & inhibitors / Sodium-Glucose Transporter 2 Inhibitors | |
Sorbitol | 182.1718 C6H14O6 | A product that can be used as a laxative to relieve constipation, and also as a urologic irrigating fluid. May also be used as a pharmaceutical sweetener. | Enemas / Osmotic Laxatives / Tests for Bile Duct Patency | |
Sorafenib | 464.825 C21H16ClF3N4O3 | A kinase inhibitor used to treat unresectable liver carcinoma, advanced renal carcinoma, and differentiated thyroid carcinoma. | Protein Kinase Inhibitors | |
Sonidegib | 485.507 C26H26F3N3O3 | An antineoplastic agent used for the treatment of locally advanced recurrent basal cell carcinoma (BCC) following surgery and radiation therapy, or in cases where surgery or radiation therapy are not appropriate. | Hedgehog pathway inhibitors | |
Somatostatin | 1637.9 C76H104N18O19S2 | A natural peptide hormone used to treat acute bleeding from esophageal varices, gastrointestinal ulcers, and gastritis; prevent pancreatic complications after surgery; and restrict secretions of the upper intestine, pancreas, and biliary tract. | Somatostatin and Analogues | |
Solriamfetol | 194.234 C10H14N2O2 | Solriamfetol is indicated for treatment of daytime sleepiness associated with obstructive sleep apnea and narcolepsy, but is not a treatment for the underlying airway obstruction in apnea patients[FDA Label][A176534,A176744]. | Centrally Acting Sympathomimetics | |
Solifenacin | 362.473 C23H26N2O2 | A muscarinic antagonist with antispasmodic properties used to treat urge urinary incontinence, urgency, and urinary frequency associated with an overactive bladder. | Drugs for Urinary Frequency and Incontinence | |
Sofpironium | 390.499 C22H32NO5 | A topical anticholinergic used to treat primary axillary hyperhidrosis. | Anticholinergic Agents / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / MATE 1 Inhibitors / MATE inhibitors / Muscarinic Antagonists / OCT1 inhibitors / OCT2 Inhibitors | |
Sofosbuvir | 529.458 C22H29FN3O9P | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. | Antivirals for treatment of HCV infections | |
Sodium zirconium cyclosilicate | 365.452 Na2O9Si3Zr | A potassium binder used to treat hyperkalemia. | Drugs for Treatment of Hyperkalemia and Hyperphosphatemia | |
Sodium tetradecyl sulfate | 316.43 C14H29NaO4S | An anionic surfactant used to treat varicose veins of the lower extremities. | Sclerosing Agents for Local Injection | |
Sodium tartrate | 194.05 C4H4Na2O6 | It acts as an emulsifier and pH control agent in food products , . In the laboratory, it is used while performing the Karl Fischer equation, which is used to... | Osmotic Laxatives |
Displaying drugs 401 - 425 of 2796 in total